KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Current Assets: 2010-2024

Historic Current Assets for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $12.3 million.

  • TherapeuticsMD's Current Assets rose 19.33% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 19.33%. This contributed to the annual value of $12.3 million for FY2024, which is 3.93% up from last year.
  • Per TherapeuticsMD's latest filing, its Current Assets stood at $12.3 million for FY2024, which was up 3.93% from $11.8 million recorded in FY2023.
  • TherapeuticsMD's 5-year Current Assets high stood at $128.4 million for FY2020, and its period low was $11.8 million during FY2023.
  • Over the past 3 years, TherapeuticsMD's median Current Assets value was $12.3 million (recorded in 2024), while the average stood at $26.5 million.
  • In the last 5 years, TherapeuticsMD's Current Assets crashed by 78.69% in 2023 and then increased by 3.93% in 2024.
  • Over the past 5 years, TherapeuticsMD's Current Assets (Yearly) stood at $128.4 million in 2020, then dropped by 6.96% to $119.5 million in 2021, then slumped by 53.67% to $55.4 million in 2022, then plummeted by 78.69% to $11.8 million in 2023, then increased by 3.93% to $12.3 million in 2024.